Literature DB >> 27519753

Effect of maternal serum on viability and function of early human placental explants.

J Begum-Hasan1, M Senterman1, P Gillett1, C L Branchaud1, B E Murphy1.   

Abstract

Fetal bovine serum (FBS) is frequently used to supplement chemically defined media such as Ham's F10 when studying placental explant cultures. However in vitro production of hormones is usually declining by the 2nd or 3rd day and is short-lived (7 to 10 days). In this study we explored the use of human maternal serum (HMS) from early gestation as the medium supplement to Ham's F10. Early placental hormone production was compared using two concentrations of FBS and HMS. On Day 3 of incubation, progesterone production in 10% HMS was 12-fold increased over that in 10% FBS, estradiol production was increased 10-fold, and βhCG production more than 3-fold. When the serum concentrations were increased to 40%, the results in all cases were similar to those at 10%. Preliminary characterization studies revealed that the stimulatory activity of HMS is heat-labile, neither extractable into organic solvent (diethyl ether) nor dialyzable, suggesting that it is protein in nature. In a long-term incubation, compared with FBS (7 days), HMS permitted survival of culture up to 30 days, judged both histologically and biochemically. We conclude that HMS provides substance(s), probably protein in nature, not present in FBS or non-pregnant human serum, which are important for human placental viability and function in vivo.

Entities:  

Keywords:  human maternal serum; placenta explant culture

Year:  1993        PMID: 27519753     DOI: 10.1007/BF02639386

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  27 in total

1.  Effects of heterologous sera on the modal distribution of variants in four strains of human epithelial cells.

Authors:  W H MURPHY; C BULLIS; B J LANDAU; R ACOSTA
Journal:  Cancer Res       Date:  1962-09       Impact factor: 12.701

2.  Estradiol assay by microtitre plate enzyme immunoassay.

Authors:  G J Marcus; R Durnford
Journal:  J Steroid Biochem       Date:  1988-02       Impact factor: 4.292

3.  A new trophoblast-derived growth factor from human placenta: purification and receptor identification.

Authors:  A Sen-Majumdar; U Murthy; M Das
Journal:  Biochemistry       Date:  1986-02-11       Impact factor: 3.162

Review 4.  Review article: the new placental proteins.

Authors:  A Klopper
Journal:  Placenta       Date:  1980 Jan-Mar       Impact factor: 3.481

5.  Metabolism of 14C-pregnenolone in the placenta throughout pregnancy in organ culture.

Authors:  M Ogino; K Kinoshita; K Satoh; M Mizuno; S Sakamoto
Journal:  Endocrinol Jpn       Date:  1983-10

Review 6.  Methods for growth of cultured cells in serum-free medium.

Authors:  D Barnes; G Sato
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

7.  Progesterone synthesis by human placental syncytiotrophoblast in vitro--preferred precursor and effect of human chorionic gonadotropin.

Authors:  S Paul; C Das; B L Jailkhani; G P Talwar
Journal:  J Steroid Biochem       Date:  1981-03       Impact factor: 4.292

8.  Human fetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy.

Authors:  R A Munsick
Journal:  Am J Obstet Gynecol       Date:  1984-08-15       Impact factor: 8.661

9.  Progesterone and estrogen production by placental monolayer cultures: effect of dehydroepiandrosterone and luteinizing hormone-releasing hormone.

Authors:  C L Branchaud; C G Goodyer; L S Lipowski
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

10.  Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta.

Authors:  D W Morrish; D Bhardwaj; L K Dabbagh; H Marusyk; O Siy
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.